Mrs Nikki Reyne

Grant-Funded Researcher (A)

School of Medicine

College of Health


Dr Nikki Reyne is the Preclincal Lead in the Respiratory X-ray Imaging Laboratory and Cystic Fibrosis Airway Research Group. Her research speacialises in pre-clinical models of respiratrory diseases, lung function assessment, and advance respiratory imgaing. 
 
Current research focuses on:

Developing and characterising preclinical models of CF and respiratory infection.
Advancing X-ray Velocimetry (XV) as a novel tool for assessing regional lung ventilation and function.
Investigating how disease progression, infection, and therapies alter lung mechanics and ventilation.
Identifying sensitive imaging biomarkers that can detect early lung disease and treatment responses.
Translating preclinical imaging discoveries toward clinical applications in CF and other respiratory diseases.
Improving understanding of lung function changes across the lifespan in chronic respiratory disease models.

I am a postdoctoral researcher working within the Adelaide Cystic Fibrosis Airway Research Group and the Respiratory X-ray Imaging Laboratory, based at the Women’s and Children’s Hospital in South Australia. My research focuses on improving the understanding, detection, and treatment of respiratory disease through the use of advanced preclinical models, functional lung imaging, and translational therapeutic approaches.

While my primary research area is cystic fibrosis (CF), my work extends broadly across respiratory disease, including muco-obstructive lung disease, chronic bacterial infections, airway obstruction, and other conditions associated with impaired ventilation and lung function. I am particularly interested in how early functional changes within the lung contribute to disease progression, and how emerging technologies can identify these changes before irreversible damage occurs.

My research journey began in 2019 when I undertook an Honours project investigating lentiviral gene therapy in a CF rat model. This work resulted in the first demonstration of in vivo CFTR correction in the nasal airway epithelium, highlighting the potential of genetic therapies to address the underlying cause of CF disease.

My PhD work focused on using X-ray Velocimetry (XV)—a novel imaging modality that captures lung function in real-time—to study respiratory disease in animal models. I have applied XV to assess lung function in CF rats, β-ENaC transgenic mice, and preclinical models of obstructive lung disease. My research has demonstrated regional ventilation differences in these models, contributing to our understanding of disease progression and treatment efficacy.

I also have an interest in bacterial lung infections, particularly Pseudomonas aeruginosa, which remains a significant challenge in CF care. I have developed and characterised a chronic Pseudomonas lung infection model in CF rats to better replicate human disease and assess therapeutic strategies.

In addition to my research responsibilities, I manage the breeding and maintenance of the only two CF rat models in the Southern Hemisphere, which are a vital resource for translational research in Australia.

Research Goals
My long-term research goal is to improve the early detection, monitoring, and treatment of respiratory disease in both paediatric and adult populations. By integrating advanced imaging technologies, functional lung assessments, and therapeutic development, I aim to better understand disease mechanisms, identify early markers of lung dysfunction, and contribute to the development of more effective and personalised respiratory treatments.

 

https://player.vimeo.com/video/1109289503?app_id=122963

Date Position Institution name
2025 - ongoing Post-doctoral Researcher Adelaide University

Date Institution name Country Title
2024 University of Adelaide Australia PhD
The University of Adelaide Australia Bachelor of Science - Animal Science
The University of Adelaide Australia Bachelor of Science (Honours)

Year Citation
2026 How, Y. Y., Reyne, N., Croughan, M. K., Cmielewski, P., Batey, D., Costello, L. F., . . . Morgan, K. S. (2026). In vivo 4D x-ray dark-field lung imaging in mice. IEEE Transactions on Medical Imaging, 45(1), 269-280.
DOI Scopus1 WoS1 Europe PMC1
2026 Reyne, N., Boog, B., Cmielewski, P., McCarron, A., Smith, R., Rout-Pitt, N., . . . Donnelley, M. (2026). A longitudinal evaluation of localised chronic Pseudomonas aeruginosa infection in cystic fibrosis rat models. BMC Microbiology, 26(1), 368-1-368-14.
DOI
2025 Smith, R., Reyne, N., Batey, D., Eikelis, N., Asselin Labat, M. -L., & Donnelley, M. (2025). Mapping lung cancer ventilation dynamics: A pilot mouse study using functional imaging and lung mechanics.. Dis Model Mech, 18(12), 9 pages.
DOI Scopus2 WoS1
2025 Rout-Pitt, N., Boog, B., McCarron, A., Reyne, N., Parsons, D., & Donnelley, M. (2025). Insights into epithelial-mesenchymal transition from cystic fibrosis rat models. Journal of Cystic Fibrosis, 24(1), 149-156.
DOI Scopus5 WoS4 Europe PMC5
2025 Dos Reis, D. C., Jin, J., Santos, A., Muiler, C., Zagoren, E., Donnelley, M., . . . Ameen, N. A. (2025). CFTR High Expresser BEST4+ cells are pH-sensing neuropod cells: new implications for intestinal physiology and Cystic Fibrosis disease.. bioRxiv.
DOI
2025 Reyne, N., Smith, R., Cmielewski, P., Eikelis, N., Nilsen, K., Louise, J., . . . Donnelley, M. (2025). Functional Lung Imaging Identifies Peripheral Ventilation Changes in ꞵ-ENaC Mice. Respirology, 30(4), 335-345.
DOI Scopus7 WoS6 Europe PMC6
2025 Feizi, S., Cooksley, C. M., Reyne, N., Boog, B., Finnie, J., Shaghayegh, G., . . . Vreugde, S. (2025). An immunocompetent rat model of Mycobacterium abscessus multinodular granulomatous lung infection. Tuberculosis, 152, 102629-1-102629-8.
DOI Scopus2 WoS2 Europe PMC1
2024 Reyne, N., Smith, R., Cmielewski, P., Eikelis, N., Lawrence, M., Louise, J., . . . Donnelley, M. (2024). Assessment of respiratory mechanics and X-ray velocimetry functional imaging in two cystic fibrosis rat models.. Scientific reports, 14(1), 21646.
DOI Scopus10 WoS8 Europe PMC9
2024 Harker, S. A., Preissner, M., Chang, R. Y., Trevascus, D., Liu, C., Wang, Y., . . . Morgan, K. S. (2024). Using X-ray velocimetry to measure lung function and assess the efficacy of a pseudomonas aeruginosa bacteriophage therapy for cystic fibrosis. Scientific Reports, 14(1), 29727-1-29727-14.
DOI Scopus4 WoS3 Europe PMC2
2024 Smith, R., Morgan, K. S., McCarron, A., Cmielewski, P., Reyne, N., Parsons, D., & Donnelley, M. (2024). Ultra-fastin-vivodirectional dark-field x-ray imaging for visualising magnetic control of particles for airway gene delivery. Phys Med Biol, 69(10), 105025-1-105025-11.
DOI Scopus3 WoS3 Europe PMC3
2024 Ousingsawat, J., Centeio, R., Reyne, N., McCarron, A., Cmielewski, P., Schreiber, R., . . . Kunzelmann, K. (2024). Inhibition of mucus secretion by niclosamide and benzbromarone in airways and intestine. Scientific Reports, 14(1), 1464-1-1464-12.
DOI Scopus8 WoS8 Europe PMC8
2024 Reyne, N., Cmielewski, P., McCarron, A., Smith, R., Eikelis, N., Pirakalathanan, P., . . . Donnelley, M. (2024). Effect of elexacaftor-tezacaftor-ivacaftor on nasal potential difference and lung function in Phe508del rats. Frontiers in Pharmacology, 15, 1-7.
DOI Scopus7 WoS10 Europe PMC9
2023 Donnelley, M., Lagerquist, L., Cmielewski, P., Reyne, N., Morgan, K., & Parsons, D. (2023). Noncontact Respiratory Motion Detection in Anesthetized Rodents. Journal of the American Association for Laboratory Animal Science.
DOI
2023 Reyne, N., McCarron, A., Cmielewski, P., Parsons, D., & Donnelley, M. (2023). To bead or not to bead: A review of Pseudomonas aeruginosa lung infection models for cystic fibrosis. FRONTIERS IN PHYSIOLOGY, 14, 13 pages.
DOI Scopus30 WoS28 Europe PMC22
2023 Donnelley, M., Lagerquist, L., Cmielewski, P., Reyne, N., Morgan, K., & Parsons, D. (2023). Noncontact Respiratory Motion Detection in Anesthetized Rodents. Journal of the American Association for Laboratory Animal Science, 62(6), 559-568.
DOI Scopus2 WoS2 Europe PMC2
2022 Donnelley, M., Cmielewski, P., Morgan, K., Delhove, J., Reyne, N., McCarron, A., . . . Parsons, D. (2022). Improved in-vivo airway gene transfer via magnetic-guidance, with protocol development informed by synchrotron imaging. Scientific Reports, 12(1), 9000-1-9000-14.
DOI Scopus2 WoS2 Europe PMC2
2022 Drysdale, V., Cmielewski, P., Donnelley, M., Reyne, N., Parsons, D., & McCarron, A. (2022). Comparison of physical perturbation devices for enhancing lentiviral vector-mediated gene transfer to the airway epithelium.. Human Gene Therapy, 33(19-20), 1062-1072.
DOI
2021 Reyne, N., Cmielewski, P., Mc Carron, A., Delhove, J., Parsons, D., & Donnelley, M. (2021). Single-dose lentiviral mediated gene therapy recovers CFTR function in cystic fibrosis knockout rats. Frontiers in Pharmacology, 12, 682299-1-682299-8.
DOI Scopus12 WoS11 Europe PMC13
2020 McCarron, A., Cmielewski, P., Reyne, N., McIntyre, C., Finnie, J., Craig, F., . . . Donnelley, M. (2020). Phenotypic characterization and comparison of Phe508del and cystic fibrosis transmembrane conductance regulator (CFTR) knockout rat models of cystic fibrosis generated by CRISPR/Cas9 gene editing. The American Journal of Pathology, 190(5), 977-993.
DOI Scopus38 WoS37 Europe PMC38

2025   M. Donnelley, D. Parsons, A. Fouras, A. Tai, N. Eikelis, D. Dharmaprani, R. Smith, N. Reyne, J. Louise. "Improving pediatric respiratory outcomes using x-ray velocimetry functional imaging." $1.9 m 

2025   A. McCarron, N. Rout-Pitt, N. Reyne, M. Donnelley. "Delivery: the final barrier to overcome for effective CF airway gene therapy." $80,000 

2024     N. Reyne, R, Smith, M. Donnelley and D. Parsons. Robinson Research Institute Step Funding. “X-ray velocimetry lung function imaging in the β-ENaC mouse model of cystic fibrosis.” $14,979.

2024     N. Rout-Pitt, A. McCarron, N. Reyne, D. Parsons. M. Donnelley. Cystic Fibrosis Foundation, "Unravelling the Role of Epithelial-Mesenchymal Transition (EMT) in Cystic Fibrosis Lung Disease: Insights, Challenges, and Therapeutic Prospects", $175,000.

2023     E. Schneider-Futschik, J. Bourke, D. Parsons, H. Chinnery. J. Taylor-Cousar, P. Middleton, A. McCarron and N. Reyne. Cystic Fibrosis Foundation “Delaying the onset of cystic fibrosis pathologies” $282,000

2023     A. McCarron, N. Reyne, P. Cmielewski, M. Donnelley, D. Parsons. Channel 7 Children’s Research Foundation. “Does the presence of lung infection impact the efficacy of cystic fibrosis airway gene therapy?” $40,060.

Date Role Committee Institution Country
2026 - ongoing Convener Small Interest Group - Cystic Fibrosis TSANZ TSANZ Australia
2025 - ongoing Member Cystic Fibrosis Conference CFA Australia

Connect With Me

External Profiles

Other Links